Results of the summarizing process for the arXiv paper: 2109.09112v1

A new report by Steven C. Quay, Daoyu Zhang, Adrian Jones, and Yuri Deigin has shed light on the detection of Nipah virus in an infectious clone format in raw RNA-Seq sequencing reads deposited by the Wuhan Institute of Virology (WIV) produced from five December 2019 patients infected with SARS-CoV-2. The Nipah virus is a BSL4-level pathogen and CDC-designated Bioterrorism Agent that has never been reported to have occurred at the WIV. While previous authors had interpreted the presence of several other viruses such as Influenza A, Spodoptera frugiperda rhabdovirus, and Nipah as indicative of co-infections or laboratory contamination, this new analysis shows that NiV genes are encapsulated in synthetic vectors for assembly of a NiV infectious clone. The study documents the finding of internal N, P-V-W-C and L protein coding sequences as well as coverage of the G and F genes. Furthermore, the format of Hepatitis D virus ribozyme and T7 terminator downstream of the 5'-prime end of the NiV sequence is consistent with truncation required at the end for a full length infectious clone. This indicates that research was being conducted on an assembled NiV infectious clone at WIV. Contamination of patient sequencing reads by an infectious NiV clone could indicate a significant breach of BSL-4 protocols. The authors call on WIV to explain the purpose behind this research on infectious clones of Nipah Virus, provide a detailed chronology regarding this work, and clarify how and when during sample preparation this contamination occurred. This new information raises concerns about biosafety practices at WIV and highlights potential risks associated with conducting research on highly pathogenic viruses like Nipah in high containment laboratories such as BSL-4 facilities.

• - A new report sheds light on the detection of Nipah virus in raw RNA-Seq sequencing reads from five December 2019 patients infected with SARS-CoV-2 at the Wuhan Institute of Virology (WIV).
• - The Nipah virus is a BSL4-level pathogen and CDC-designated Bioterrorism Agent that has never been reported to have occurred at the WIV.
• - NiV genes are encapsulated in synthetic vectors for assembly of a NiV infectious clone, indicating research was being conducted on an assembled NiV infectious clone at WIV.
• - Contamination of patient sequencing reads by an infectious NiV clone could indicate a significant breach of BSL-4 protocols.
• - The authors call on WIV to explain the purpose behind this research on infectious clones of Nipah Virus, provide a detailed chronology regarding this work, and clarify how and when during sample preparation this contamination occurred.
• - This raises concerns about biosafety practices at WIV and highlights potential risks associated with conducting research on highly pathogenic viruses like Nipah in high containment laboratories such as BSL-4 facilities.

There is a report about finding a virus called Nipah in some samples from people who had another virus called SARS-CoV-2. Nipah is a very dangerous virus that has never been found at the lab where these samples were taken. Scientists were working on making a copy of the Nipah virus, which could be risky if it got mixed up with the patient samples. The authors of the report want the lab to explain why they were studying this virus and how it got mixed up with patient samples. This shows that labs need to be very careful when working with dangerous viruses like Nipah. Definitions- Nipah virus: A highly contagious and deadly virus that can cause severe respiratory illness or encephalitis (inflammation of the brain). - RNA-Seq sequencing reads: A technique used to analyze gene expression by sequencing RNA molecules. - SARS-CoV-2: The coronavirus responsible for causing COVID-19. - BSL4-level pathogen: A pathogen that requires maximum containment measures due to its high risk of transmission and/or severity of disease it causes. - CDC-designated Bioterrorism Agent: A biological agent identified by the Centers for Disease Control and Prevention as having potential use in bioterrorism attacks. - NiV infectious clone: A genetically engineered version of the Nipah virus that can replicate itself in cells.

Nipah Virus Detected in Infectious Clone Format at Wuhan Institute of Virology

A new report by Steven C. Quay, Daoyu Zhang, Adrian Jones, and Yuri Deigin has shed light on the detection of Nipah virus (NiV) in an infectious clone format in raw RNA-Seq sequencing reads deposited by the Wuhan Institute of Virology (WIV). This is a significant finding as NiV is a BSL4-level pathogen and CDC-designated Bioterrorism Agent that has never been reported to have occurred at the WIV.

Background on Nipah Virus

Nipah virus is an emerging zoonotic paramyxovirus that was first identified during an outbreak of encephalitis and respiratory illness among pig farmers in Malaysia and Singapore in 1998. It can cause severe disease with high mortality rates among humans who are infected with it. The virus can also be transmitted from person to person through direct contact or through airborne droplets from coughing or sneezing. In addition to humans, NiV can infect pigs, horses, cats, dogs, goats, sheep and bats.

Previous Research Findings

Previous authors had interpreted the presence of several other viruses such as Influenza A, Spodoptera frugiperda rhabdovirus and Nipah as indicative of co-infections or laboratory contamination due to sample preparation procedures conducted at WIV. However this new analysis shows that NiV genes are encapsulated in synthetic vectors for assembly of a NiV infectious clone which indicates that research was being conducted on an assembled NiV infectious clone at WIV.

Findings From New Report

The study documents the finding of internal N, P-V-W-C and L protein coding sequences as well as coverage of the G and F genes within these samples taken from five December 2019 patients infected with SARS-CoV-2. Furthermore, the format of Hepatitis D virus ribozyme and T7 terminator downstream of the 5'-prime end of the NiV sequence is consistent with truncation required at the end for a full length infectious clone indicating contamination by an infectious NiV clone could indicate a significant breach of BSL-4 protocols at WIV .

Implications & Recommendations

This new information raises concerns about biosafety practices at WIV and highlights potential risks associated with conducting research on highly pathogenic viruses like Nipah in high containment laboratories such as BSL-4 facilities. The authors call on WIV to explain the purpose behind this research on infectious clones